Frederic H. Moll - 17 Sep 2021 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
Director
Signature
/s/ Alaleh Nouri, Attorney-in-Fact for Frederic Moll
Issuer symbol
PRCT
Transactions as of
17 Sep 2021
Net transactions value
+$10,000,000
Form type
4
Filing time
21 Sep 2021, 18:34:49 UTC
Previous filing
14 Sep 2021
Next filing
01 Dec 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Conversion of derivative security +329,890 +216% 482,521 17 Sep 2021 Direct F1
transaction PRCT Common Stock Purchase $10,000,000 +400,000 +83% $25.00 882,521 17 Sep 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRCT Series B Convertible Preferred Stock Conversion of derivative security -45,586 -100% 0 17 Sep 2021 Common Stock 45,586 $0.000000 Direct F1
transaction PRCT Series C Convertible Preferred Stock Conversion of derivative security -89,840 -100% 0 17 Sep 2021 Common Stock 89,840 $0.000000 Direct F1
transaction PRCT Series D Convertible Preferred Stock Conversion of derivative security -108,214 -100% 0 17 Sep 2021 Common Stock 108,214 $0.000000 Direct F1
transaction PRCT Series E Convertible Preferred Stock Conversion of derivative security -9,104 -100% 0 17 Sep 2021 Common Stock 9,104 $0.000000 Direct F1
transaction PRCT Series F Convertible Preferred Stock Conversion of derivative security -16,974 -100% 0 17 Sep 2021 Common Stock 16,974 $0.000000 Direct F1
transaction PRCT Series G Convertible Preferred Stock Conversion of derivative security -60,172 -100% 0 17 Sep 2021 Common Stock 60,172 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date.
F2 Represents a purchase in the Issuer's public offering.